ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Puretech Health Plc

Puretech Health Plc (PRTC)

140.00
-3.00
(-2.10%)
Closed 12 January 3:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
140.00
Bid
139.40
Offer
140.00
Volume
886,955
139.40 Day's Range 146.00
138.00 52 Week Range 238.50
Market Cap
Previous Close
143.00
Open
144.40
Last Trade Time
Financial Volume
1,260,940p
VWAP
142.165
Average Volume (3m)
773,330
Shares Outstanding
239,421,312
Dividend Yield
-
PE Ratio
-5.08
Earnings Per Share (EPS)
-0.27
Revenue
65.12M
Net Profit
-65.7M

About Puretech Health Plc

Sector
Home Health Care Services
Industry
Home Health Care Services
Headquarters
London, Gbr
Founded
-
Puretech Health Plc is listed in the Home Health Care Services sector of the London Stock Exchange with ticker PRTC. The last closing price for Puretech Health was 143p. Over the last year, Puretech Health shares have traded in a share price range of 138.00p to 238.50p.

Puretech Health currently has 239,421,312 shares in issue. The market capitalisation of Puretech Health is £342.37 million. Puretech Health has a price to earnings ratio (PE ratio) of -5.08.

PRTC Latest News

PureTech receives FDA fast track designation for leukemia treatment

PureTech Health PLC on Thursday said that the US Food & Drug Administration has granted fast track designation to its ...

PureTech Health PLC PRTC's LYT-200 Gets Fast Track Designation in AML

PureTech Health PLC 09 January 2025   9 January 2025 PureTech Health plc   PureTech Receives FDA Fast Track Designation for LYT-200 in Acute Myeloid Leukemia (AML)   Single agent and...

PureTech Health PLC PureTech to Present at the JP Morgan Conference

PureTech Health PLC 08 January 2025   8 January 2025 PureTech Health plc   PureTech to Present at 43rd Annual J.P. Morgan Healthcare Conference   PureTech Health plc (Nasdaq: PRTC, LSE: PRTC...

PureTech Health PLC PureTech Appoints UBS as UK Corporate Broker

PureTech Health PLC 06 January 2025   6 January 2025   PureTech Health plc   PureTech Appoints UBS as UK Corporate Broker   PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the...

IN BRIEF: PureTech Health says LYT-100 slows lung function decline

LC - Boston, Massachusetts-based biotechnology company - Notes that deupirfenidone, also known as LYT-100, slows lung ...

PureTech Health PLC PRTC's Ph2b in IPF Successful; New SOC Potential

PureTech Health PLC 16 December 2024   THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU 596/ 2014) AS IT FORMS...

PureTech Health PLC Holding(s) in Company

PureTech Health PLC 11 December 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BY2Z0H74 Issuer Name PURETECH HEALTH PLC UK or Non-UK Issuer UK 2...

PureTech Health PLC PRTC's Seaport Presents Ph1 SPT-300 Data at ACNP

PureTech Health PLC 11 December 2024   11 December 2024   PureTech Health plc   PureTech Founded Entity Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP...

PureTech Health PLC PRTC Presents LYT-200 Phase 1b Data in AML at ASH

PureTech Health PLC 09 December 2024   9 December 2024 PureTech Health plc   PureTech Presents Data for LYT-200 (anti-galectin-9 monoclonal antibody) for Relapsed/Refractory AML/MDS at the...

TOP NEWS: Retail pair and under-pressure Vistry booted out of FTSE 100

Frasers Group PLC has been relegated from the FTSE 100 index in its latest quarterly shuffle alongside two constitue ...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-13.8-8.97269180754153.8153.8138620710143.75416132DE
4-26-15.66265060241661781381078267156.1391277DE
12-12.4-8.13648293963152.4178138773330160.59438857DE
26-35-20175186.4138658443158.40655014DE
52-67.5-32.5301204819207.5238.5138552867177.49789981DE
156-151-51.8900343643291300138407948198.27417616DE
260-150-51.724137931290446138335856230.69698806DE

PRTC - Frequently Asked Questions (FAQ)

What is the current Puretech Health share price?
The current share price of Puretech Health is 140.00p
How many Puretech Health shares are in issue?
Puretech Health has 239,421,312 shares in issue
What is the market cap of Puretech Health?
The market capitalisation of Puretech Health is GBP 342.37M
What is the 1 year trading range for Puretech Health share price?
Puretech Health has traded in the range of 138.00p to 238.50p during the past year
What is the PE ratio of Puretech Health?
The price to earnings ratio of Puretech Health is -5.08
What is the cash to sales ratio of Puretech Health?
The cash to sales ratio of Puretech Health is 5.13
What is the reporting currency for Puretech Health?
Puretech Health reports financial results in USD
What is the latest annual turnover for Puretech Health?
The latest annual turnover of Puretech Health is USD 65.12M
What is the latest annual profit for Puretech Health?
The latest annual profit of Puretech Health is USD -65.7M
What is the registered address of Puretech Health?
The registered address for Puretech Health is C/O TMF GROUP, 13TH FLOOR, ONE ANGEL COURT, LONDON, EC2R 7HJ
What is the Puretech Health website address?
The website address for Puretech Health is www.puretechhealth.com
Which industry sector does Puretech Health operate in?
Puretech Health operates in the HOME HEALTH CARE SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SCGLSealand Capital Galaxy Limited
4.60p
(43.75%)
10.46M
APHAlliance Pharma Plc
61.10p
(37.77%)
39.55M
NFXNuformix Plc
0.065p
(36.84%)
93.97M
PRMProteome Sciences Plc
4.50p
(31.58%)
1.06M
RCGHRc365 Holding Plc
2.10p
(31.25%)
2.88M
NTQEnteq Technologies Plc
0.775p
(-75.00%)
7.81M
JWNGJaywing Plc
0.625p
(-58.33%)
1.91M
MFAIMindflair Plc
0.825p
(-28.88%)
119.03M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
GEXGeorgina Energy Plc
6.625p
(-22.06%)
5.72M
TRPTower Resources Plc
0.0395p
(6.76%)
9.11B
NTVONativo Resources Plc
0.002p
(-9.09%)
1.27B
DGIDg Innovate Plc
0.0185p
(0.00%)
544.86M
WBIWoodbois Limited
0.135p
(-22.86%)
447.57M
MSMNMosman Oil And Gas Limited
0.033p
(-2.94%)
445.45M

Discussion

View Full Feed
leavetheguntakethecannolis leavetheguntakethecannolis 13 minutes ago
4 days does seem like a long time to wait for a response. Especially when it's the same poster.
IPIX
leavetheguntakethecannolis leavetheguntakethecannolis 14 minutes ago
4 million does not equal 1.4 million and 1.4 million does not equal 4 million. Only in agenda driven mathematics is this the case.
IPIX
ORCA ORCA 16 minutes ago
BRO 1 MILLION SHARES DID DAMAGE??LMAO.IS THE CD THAT HATES TO SEE ANY SELLER.
AXXA
Don Faton Don Faton 17 minutes ago
Email got hacked unfortunately my twitter page has the new one.   Thanks PB 
SRNW
Don Faton Don Faton 18 minutes ago
Can we be all friends.  

I would like to know when sharp will tweet again and pull his head out of his ass. 

When we getting the supposed name and ticker change.  Nothing like the stock price bleeding down. As usual.  So frustrating 
WNFT
EmpressMonk25 EmpressMonk25 21 minutes ago
If you did your homework, it was clear the company had impressive products; the fault in progress was with Gensler, and the price was actually rock bottom.

Perhaps you were not paying attention, or maybe the accusations of Foote being a criminal and claims of this being the greatest s
HMBL
jimr1717 jimr1717 22 minutes ago
🏆️ Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analytic, Inc.
30,000,000 Share
ATMH
jondoeuk jondoeuk 22 minutes ago
KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
NVCR
Golden Cross Golden Cross 23 minutes ago
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Golden Cross Golden Cross 25 minutes ago
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Kool Aid Man Kool Aid Man 25 minutes ago
I can't wait for the PR explaining the need for 700 million more shares. Never ending source of entertainment
SPZI
dstock07734 dstock07734 25 minutes ago
Gary,

I strongly suggest you go through the details of all the outcome measures adopted in the combo trial. They are so disruptive. I also think we should abandon the old concept about the definition of phase on clinical trials. The phase definition for DCVax-L doesn't matter. What it
NWBO
manibiotech manibiotech 26 minutes ago
Yep you did get it straight .
There is a reason companies apply to FDA and EMA . And there is reason for current SP.
But problem is that when given  straight to you , you can't comprehend straightforward reasons 
NWBO
Lime Time Lime Time 27 minutes ago
Very good opportunity
GVSI
gshores gshores 31 minutes ago
Nothing personal, but you reek of desperation for some reason. Longs will do great here.
SPZI
jondoeuk jondoeuk 32 minutes ago
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
NVCR
kBletsgo30 kBletsgo30 33 minutes ago
Yeah right 
RSPI
ddls ddls 33 minutes ago
Maybe you should double down, buy 10M shares...😎

Just watch out for these types of days..."1/3/25, Buy: 1,300,000, Neutral: 366,005, Sell: 66,963,117.😎

You'll be seeing more of them.
BIEL
XMaster2023 XMaster2023 37 minutes ago
I would take your bet but you have the ethics of someone who would work for an idiot who would try to kill a cure for cancer. Thus, I would never trust you!
NWBO
manibiotech manibiotech 39 minutes ago
And someone to pay NWBO ( not advent ) for those treatments 
NWBO
StockItOut StockItOut 42 minutes ago
Are they really? That's evidence of a scam.
XERI
skitahoe skitahoe 42 minutes ago
Dstocks, it's clear that many are interested in the kind of work we're doing. My question is, are any beyond the Phase 1/2 trials.

I believe we're clearly the leaders here and with approvals while it may make it easier for others, they'll still be many years before the can possibly g
NWBO
vinmantoo vinmantoo 44 minutes ago
Have you seen the stock price?

Enough said.

The stock price alone certainly isn't enough said.
Eagle1 Eagle1 47 minutes ago
SDCRBS, Please let me know if I can help you in any way. Just DM me. I'm sorry and sad to see all this CA and LA destruction.

I'm in the Houston area and couldn't imagine this type of destruction.

So Sorry.
GDVM
Plasmode Plasmode 51 minutes ago
I’ve learned so much from valuable contributors like Mr C and Dino and great respects for your researches and insights, then this kind of bickering just knock you off the pedestal into muck. Just respond with ‘next’ if you refuse to lower yourself into the mud. I have more respect for people like
TGLO